Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis
About this item
Full title
Author / Creator
Uzawa, Akiyuki , Suzuki, Shigeaki , Kuwabara, Satoshi , Akamine, Hiroyuki , Onishi, Yosuke , Yasuda, Manato , Ozawa, Yukiko , Kawaguchi, Naoki , Kubota, Tomoya , Takahashi, Masanori P. , Suzuki, Yasushi , Watanabe, Genya , Kimura, Takashi , Sugimoto, Takamichi , Samukawa, Makoto , Minami, Naoya , Masuda, Masayuki , Konno, Shingo , Nagane, Yuriko and Utsugisawa, Kimiaki
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
The efficacy of intravenous high-dose methylprednisolone (IVMP) in ocular myasthenia gravis (MG) has not been fully established. This study aimed to elucidate the effects of early intervention with IVMP for achieving the therapeutic targets (minimal manifestations [MM] or MM or better status with prednisolone ≤ 5 mg/day [MM5mg]) in ocular MG. In th...
Alternative Titles
Full title
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis
Authors, Artists and Contributors
Author / Creator
Suzuki, Shigeaki
Kuwabara, Satoshi
Akamine, Hiroyuki
Onishi, Yosuke
Yasuda, Manato
Ozawa, Yukiko
Kawaguchi, Naoki
Kubota, Tomoya
Takahashi, Masanori P.
Suzuki, Yasushi
Watanabe, Genya
Kimura, Takashi
Sugimoto, Takamichi
Samukawa, Makoto
Minami, Naoya
Masuda, Masayuki
Konno, Shingo
Nagane, Yuriko
Utsugisawa, Kimiaki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10121971
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10121971
Other Identifiers
ISSN
1933-7213,1878-7479
E-ISSN
1878-7479
DOI
10.1007/s13311-022-01335-3
